5,12,13 These efforts have yielded six GLP-1 RAsstarting with the development of exendin-4 (Figure 1B)-based exenatide (Figure 1C), followed by liraglutide (Figure 1D), albiglutide, dulaglutide (Figure 1E), lixisenatide, and semaglutide (Figure 1F)that have been approved by the United States Food and Drug Administration (US FDA) to treat type 2 diabetes
We used hierarchical clustering to identify co-expression gene modules and integrated modules with a connection degree (feature factor) greater than 0.75 to identify the most relevant modules for IAV infection characteristics
doi: 10.1515/revneuro-2024-0040 284 YuH.KirkpatrickI
A standard mixture of TAG 48:1 (C15:0/C18:1/C15:0), DAG 33:1 (C15:0/C18:1), and monoglyceride 18:1 (C18:1), purchased from Avanti Polar Lipids (Alabaster, USA), was employed as internal standard
Post hoc analyses following ANOVA were conducted using Bonferroni corrections